Skip Navigation Links
Skip Navigation Links
Skip Navigation Links
Over Active Bladder –Quality of Life Implications
OAB is a clinical syndrome defined as urgency with or without urge incontinence usually with frequency and nocturia. It is a common problem: one... Read More
Over Active Bladder –Quality of Life Implications
OAB is a clinical syndrome charectarized by urgency, frequency, nocturia and incontinence usually.  This syndrome affects  greatly the quality of life.

OAB is a clinical syndrome defined as urgency with or without urge incontinence usually with frequency and nocturia. It is a common problem: one European survey of 16776 people aged 40 or older found an overall prevalence of over active bladder symptoms were frequency (85 per cent), urgency (54 per cent) and urge incontinence (36 per cent).

The overall prevalence of OAB is similar in men and women but incontinence is more common and symptoms worsen sooner among women. prevalence increases differently with age from 9 per cent in women and 3 per cent in men aged 40-44, 31 and 42 per cent respectively at age 75 or older.

OAB adversely affects quality of life in about 30 per cent of people aged 40 or older in UK, with a significant impact on social and physical functioning, emotion and particularly mobility in women. There is also a significant detrimental effect on mood and quality of sleep .Urinary urgency is the symptom patients say is most troubling, with the greater impact on quality of life than incontinence, frequency or nocturia.

Overall the impact of OAB on quality of life reported by patients is comparable with that associated with diabetes.

Concordance issues in OAB
Despite the associated morbidity many patients do not take their medication as prescribed or discontinue treatment. In one randomized trial involving 348 patients with OAB (defined as detrusor instability), of the 256 who could be followed up, only 18 percent has persisted with anticholinergic drug treatment for at least 6 months
Three analyses of US medical claims databases found that few patient persist with treatment for a year ,even with newer modified – release formulations that are claimed to reduce adverse effects.

In one, 47 per cent of patients taken an anticholinergic drug had stopped treatment after 3 months and 82 per cent had stopped by the year's end ; the mean duration of treatment was 86 days.
The second analysis found that 88 per cent of patients stopped treatment within a year , mostly within 6 months and only 15 per cent of patient took at least 80 per cent of their prescribed medication .
In the third, the mean duration of treatment for first time users of anticholinergic drugs was 91 days with oxybutynin and 143 days with tolterodine.

Theses studies did not investigate the reasons for this early discontinuation of treatment but it is likely that lack of effectiveness and adverse effects are the most common causes.

Adherence to treatment could be improved by adopting a joint approach between patient and healthcare provider. To achieve this ,clinicians need to enquire about patients' beliefs and concerns about their condition and its treatment and give them autonomy in decision making .in turn, patients need to understand their condition and the options for treatment they should have realistic expectations of what can be achieved with drug treatment and of the nature and likely hood of adverse effects so they can agree suitable goals and they should be offered ongoing support .

Finally, treatment should deliver an improvement in symptoms without the penalty of intolerable adverse effects .

Adapted from wagg, A; Maffatt, J.; and spinks, J.eds.confidence through bladder control .the role of propverine – current thinking
1- Abrams p, cardozo L, fall M,et al.the standardization of terminology of lower urinary tract function : report from the standardization sub committee of the international continence society . neurourol urodynamics 2002;21:167-78

2- milsom 1 , Abrams P,cardozo L, et al . How widespread are the symptoms of an overactive bladder and how are they managed? A population- based prevalence study. BJU int 2001; 87:760-6.

3- Mcgrother CW, Donaldson MM,shaw C,etal storage symptoms of the bladder : prevalence incidence and need for services in the UK.BJU Int 2004;93:763-9.

4- Strew WF,van rooyen JB,cundiff Gw,etal prevalence and burden of overactive bladder in the united states world J urol  2003;20:327-36.

5- van der vaart CH , De Leeuw JR , Roovers JP, et al. the effect of urinary incontinence and over active bladder symptoms on quality of life in young women.BJU Int 2002;90:544-9.

6- coyne KS, Zhou Z thomptoms c.versi E.the impact of urinary urgency and frequency on health-related quality of life in overactive bladder : results from a national community survey.value health 2004;7:455-63.

7- Kelleher CJ,Cardozo LD, Khuller V,et al a medium term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder compiliance. Br J Obstel Gynaecol 1997;104:988-93.

8- Mcghan wf.cost effectiveness and quality of life considerations in the treatment of patients with overactive bladder .Am J manage care 2001;7:62-75

9- Noe L, sneeringer R, patel B, et al .the implications of poor meducation persistence with treatment for overactive bladder.manag care interface 2004:17:54-60.

10- Chui MA,Williamson T,Arciniegra J et al .patient persistency with medications for overactive bladder .value health 2004;7:366(abstract).

11-YU YF, Yu AP , Ahn J, et al. Medication treatment persistence of overactive bladder /urinary incontinence patients in a California Medicaid program and the benefit of their refill adherence on urinary tract infection .value health 2003;6:191.

12-Zhou Z, Barr C, Torigoe Y, et al. persistence of therapy with drugs for overactive bladder value health 2001;4:161(abstract)

13- Dowell J.Jones A, Snadden D .exploring medication use to seek concordance with non adherent' patients: a qualitative study. Brj Gen pract 2002;52:24-32.

Alzheimer's blood test detects brain damage years before symptoms
Testing blood levels of a protein that brain cells leak when faulty or dying detected people with Alzheimer's disease years before their symptoms emerged.
Stool transplants from 'super donors' could be a cure-all
New research suggests that fecal transplants from 'super donors' could cure a host of conditions, ranging from irritable bowel syndrome to Alzheimer's.
Alzheimer's: What leads to brain cell damage?
The toxic beta-amyloid protein inactivates a protein that is key to the functioning of the parts of brain cells that receive signals from other cells.
Leaky blood vessels may trigger Alzheimer's
According to a recent study, leaky capillaries could be more important to the development of Alzheimer's disease than protein buildup in the brain.
Stress may raise the risk of Alzheimer's disease
A Danish population-based study finds a strong link between psychological distress and the risk of developing Alzheimer's disease.
Experimental drug may prevent Alzheimer's disease
A drug that researchers are testing against a range of conditions might also prevent Alzheimer's. The drug blocks toxic protein buildup in the brain.
A lack of deep sleep could indicate Alzheimer's development
Sleep is vital to many aspects of well-being. A new study finds that older adults who are not getting enough quality sleep may be developing Alzheimer's.
Exercise can help fight off Alzheimer's, but how?
Why does exercise have a protective effect on our memory? A new study conducted primarily in mice identifies a major factor that determines this effect.
Alzheimer's: 9 new genetic risk factors found
The largest genetic study of Alzheimer's to date finds nine entirely new genetic locations that contribute to the risk of developing the disease.
Nutrient in mother's diet may help fight Alzheimer's in offspring
Generations of mice descended from females whose diet was high in choline had fewer Alzheimer's hallmarks in the brain and better memory function.
Candida infection can reach brain and impair memory
New research shows that the Candida albicans fungus may lead to brain inflammation and impair memory in mice. The results have implications for dementia.
What were the most intriguing medical studies of 2018?
As 2018 slowly but surely draws to a close, we give you an overview of some of the most read and thought-provoking medical research of this year.
6 months of exercise may reverse mild cognitive impairment
A new study finds that 6 months of exercise, when added to dieting, can reverse 9 years of decline in certain cognitive functions.
Alzheimer's: Study zeroes in on brain's weakest link
In a new study, researchers find out which brain cells are most vulnerable to the accumulation of toxic plaques that drive Alzheimer's and speculate why.
Type 2 diabetes and cognitive decline: Study finds link
New research examines cognitive function and brain atrophy in both people with and without type 2 diabetes over the course of approximately 5 years.
Future of Alzheimer's therapy: What is the best approach?
A new comprehensive review assesses current clinical trials for Alzheimer's drugs and advises on the best therapeutic approach going forward.
A new blood test could help diagnose Alzheimer's
New research focuses on an accurate blood test for Alzheimer's disease. If scientists replicate the study's promising results, it may be a breakthrough.
Dementia: Gene study boosts search for treatment
Using an innovative analytical approach, researchers pinpointed genes that play an important role in the protein buildup associated with dementia.
Gun ownership and dementia: A growing concern
As the older population of the United States grows, the prevalence of dementia also rises. A new paper discusses dementia and gun ownership.
Lung disease may increase dementia risk
New research uncovers another potential risk factor for dementia and, more generally, for cognitive impairment, namely having a lung disease in midlife.
Alzheimer's may soon be treated with HIV drugs
For the first time, scientists show how the gene that produces brain toxicity in Alzheimer's is 'recombined' using the same enzyme found in HIV.
Men who eat lots of fruits and vegetables have less memory loss
Consumption of orange juice, certain vegetables, leafy greens, and berry fruits is tied to less memory loss in a large group of men followed for 26 years.
Could managing cholesterol prevent Alzheimer's?
The largest genetic study of Alzheimer's to date finds that this neurological disease shares some genetic risk factors with several cardiovascular conditions.
Alzheimer's vaccine draws closer
Building on more than a decade of scientific research, a recent paper brings us one step closer to developing a vaccine for Alzheimer's disease.
A simple type of daily meditation may alter the course of Alzheimer's
Simple mind-body practices altered potential cell aging and Alzheimer's biomarkers. The changes linked directly to improved cognition and other functions.
<January 2019>
Home | Partners | Products | Researches| Monthly Articles | Distribution| Marketing | Useful Links | Careers | Contact Us | Site Map
Site Developed By Netegypt © 2010 TCHERO. All Rights Reserved.